The BareStory
The Trump administration has reversed a decision to cancel nearly $2 billion in federal grants designated for mental health and addiction treatment programs. The reinstatement, confirmed late Wednesday, restores funding for approximately 2,700 discretionary grants managed by the Substance Abuse and Mental Health Services Administration (SAMHSA) that had been terminated earlier in the week.
Representative Rosa DeLauro, the ranking Democrat on the House Appropriations Committee, stated that Health Secretary Robert F. Kennedy Jr. restored the awards following public pressure. Administration officials and congressional aides subsequently confirmed the reversal. The initial termination notices, signed by a senior SAMHSA official, stated the agency was adjusting its portfolio to prioritize resources for addressing rising rates of substance abuse, overdose, suicide, and mental illness.
The affected funding supports various community-based initiatives, including youth overdose prevention, medication-assisted treatment, and the Opioid Response Network. While the termination notice cited resource prioritization, a source familiar with the matter alleged the move was initiated by political appointees rather than career officials. The policy shift occurs as the agency faces significant personnel changes; data from the Office of Personnel Management indicates that SAMHSA’s workforce has decreased from 916 employees in 2024 to 547.
How it may affect me
As a U.S. reader:
• Communities can expect continued access to youth overdose prevention and medication-assisted treatment programs that utilize this $2 billion in federal funding.
• The Opioid Response Network and similar local initiatives will avoid immediate service disruptions that would have occurred under the initial termination notices.
• Grant recipients may experience management or oversight challenges as the federal agency responsible for these funds operates with a significantly reduced workforce.
• Future funding for mental health programs may face uncertainty as the administration continues to review discretionary portfolios to prioritize resources for rising health crises.